Will NJ become the first state to ban corporate tax inversions?
Some lawmakers in the New Jersey state legislature recently announced plans to remove incentives and cut contracts with U.S. companies that move offshore for tax purposes. According to a NorthJersey.com report, the proposed law changes are the direct result of Pfizer Inc.’s merger with Allergan PLC in Ireland in an attempt to lower its corporate tax rate.
The objective of the proposed legislation
The federal government recently announced changes to offshore disclosure and tax inversion laws to limit the corporate tax incentives. However, the NorthJersey.com report showed that New Jersey would be the first state in the country to remove these contracts and incentives for U.S. companies headquartered in their states. According to a NorthJersey.com interview with Sen. Shirley Turner, a Lawrenceville Democrat, this legislation would be an opposition to Gov. Chris Christie’s push to the federal government to lower corporate taxes.
“I want to send a strong message to Pfizer as well as any other corporate deserters looking to do the same thing,” Turner explained. “They are parasites living off of our taxpayers, and it’s not like they’re going bankrupt by any means.”
The background of the merger
The Allergan PLC and Pfizer Inc. merger is significant because the $160 billion partnership would create the largest corporate tax inversion in the world. As both companies have operating headquarters in New Jersey and Ireland, the merger makes sense from an operations standpoint, but it also represents a recent trend. Many U.S. companies have effectively completed tax inversions in Ireland in the last few years because of its 12.5 percent corporate tax rate. Currently, the corporate tax rate in the U.S. is 35 percent. While many U.S. companies pay far less than the nominal rate, it still makes Ireland a desirable destination for larger domestic companies.
Criticism
One of the most significant arguments against this newly proposed legislation at the state level is that the federal government has not made corporate tax inversions less profitable. Therefore, if the federal government fails to address the problems that contribute to higher numbers of offshore tax evasion for larger companies, states like New Jersey do not have the resources to keep those tax dollars. In a statement cited by NorthJersey.com, Joan Campion, a Pfizer spokesperson, agreed with Christie’s criticism of the proposed legislation because it only stimulates more corporate tax inversions.
“This legislation discourages investment in New Jersey,” Campion argued. “A reformed tax code that includes a territorial system would stimulate investment in the United States and allow American businesses to compete on a level playing field.”
IP Infringement: What Steps Can You Take If You're Affected?
IP infringement occurs when someone uses your intellectual property without your permission or beyond the scope of the permission you granted. Common examples of IP infringement include copying a product’s patented features or using a trademarked logo in a way that is likely to confuse consumers about the source or affiliation of goods or services. […]
Public Allegations, Unfinished Investigation: What New Jersey Businesses Should Do Next
When facing public allegations of wrongdoing, companies should not let the speed of the public conversation dictate the speed of an investigation. An investigation designed to confirm a preferred narrative rather than establish the facts can create serious problems later, particularly if litigation, regulatory scrutiny, or employment claims follow. Key Takeaways When public allegations surface […]
BESS Interconnection: Managing Grid, Cost, and Schedule Risk
For battery energy storage system (BESS) developers, securing equipment and site control is only part of the development equation. A project must also connect to the electric grid, and increasingly, BESS interconnection is one of the biggest sources of schedule, cost, and contractual risk. Key Takeaways This article is Part 3 of our Battery Storage […]
Navigating Director and Officer Liability in Times of Financial Distress
Director and officer liability increases sharply when a company is in financial distress. Decisions that would draw little attention in a healthy business can later be challenged by creditors, shareholders, bankruptcy trustees, and regulators as breaches of fiduciary duty, fraudulent transfers, or oversight failures. Understanding where that exposure comes from, and how to manage it, […]
Before You Buy: Managing Real Estate and Permitting Risk for BESS Projects in New York and New Jersey
For developers pursuing battery energy storage system (BESS) projects, finding the right property is only the beginning. BESS site selection is as much a legal and transactional exercise as a real estate decision, with risk analysis central to the project’s ultimate success. Key Takeaways The core questions for BESS site selection in New York and […]
What Business Owners Get Wrong Before Meeting a Litigation Attorney
What should you expect when meeting a litigation attorney about a business dispute? You should expect to describe the dispute in your own words, hand over the most important documents, flag any deadlines or immediate threats, and leave with a clearer picture of the problem, what information is still needed, and the likely next steps. […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
